New project: InnerVoice

Wyss Center’s ABILITY system, designed to improve quality of life and independence for people with severe paralysis, demonstrates safety and efficacy in pre-clinical trials.

New Wyss Center whitepaper reveals first neural signals recorded by the ABILITY brain-computer interface system and the next steps to human clinical trials to restore communication and independence for people with severe paralysis.

Two-year study paves the way for new technologies for people with severe paralysis

Early clinical study will assess safety and feasibility of the Epios™ subscalp recording leads in epilepsy patients

The cloud-based platform enables long-term brain monitoring towards personalized treatment.

The Wyss Center’s spin-off company Epios joins a global network of entrepreneurs with its long-term brain monitoring technology.

Results demonstrate MRI compatibility, good surgical handling and reliable recording in bioelectronic interfaces that conform to the nervous system.

Subscalp brain monitoring devices could offer long-term, continuous, and reliable recording of neural activity at home and in the clinic.

Personalized neurotech could boost rehab success.

Recent advances in DBS could lead to treatments for obsessive-compulsive disorder, Gilles de la Tourette syndrome and depression.